Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study
暂无分享,去创建一个
Aravinda Chakravarti | Richard S Cooper | A. Chakravarti | R. Cooper | G. Ehret | A. Weder | Georg B Ehret | Ashley A O'Connor | Alan Weder | R. Cooper
[1] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[2] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[3] N. Schork,et al. A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. , 2003, American journal of hypertension.
[4] E. Boerwinkle,et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. , 2007, American journal of human genetics.
[5] Fuli Yu,et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. , 2005, Genome research.
[6] Nuala A Sheehan,et al. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.
[7] R. Klausner,et al. Molecular cloning of the zeta chain of the T cell antigen receptor. , 1988, Science.
[8] H. Brunner,et al. Aliskiren: the first renin inhibitor for clinical treatment , 2008, Nature Reviews Drug Discovery.
[9] Ronald W. Davis,et al. Multiplexed genotyping with sequence-tagged molecular inversion probes , 2003, Nature Biotechnology.
[10] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.
[11] M. Margaglione,et al. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. , 2000, British journal of haematology.
[12] F. Triposkiadis,et al. Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. , 2000, American journal of hypertension.
[13] P. Hardenbol,et al. Optimal genotype determination in highly multiplexed SNP data , 2006, European Journal of Human Genetics.
[14] R. Moritz,et al. The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] Martin G. Larson,et al. Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study , 2001, Circulation.
[16] Eric Boerwinkle,et al. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program , 2008, European Journal of Human Genetics.
[17] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[18] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[19] E. O’Brien,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.
[20] Christoph Lange,et al. A multivariate family-based association test using generalized estimating equations: FBAT-GEE. , 2003, Biostatistics.
[21] Steven C. Hunt,et al. Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). , 2002, Hypertension.
[22] G. Abecasis,et al. Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.
[23] A. Stanton,et al. Renin Gene Polymorphisms and Haplotypes, Blood Pressure, and Responses to Renin-Angiotensin System Inhibition , 2007, Hypertension.
[24] P. Wilson,et al. Established risk factors and coronary artery disease: the Framingham Study. , 1994, American journal of hypertension.